Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection.
J Clin Virol
; 48(1): 15-7, 2010 May.
Article
en En
| MEDLINE
| ID: mdl-20362493
ABSTRACT
BACKGROUND:
Despite considerable evolution in the quality of laboratory-based testing for detection of HCV, the availability of rapid, point-of-care tests may increase diagnoses by increasing opportunities for testing outside of traditional laboratory settings.OBJECTIVES:
We evaluated the performance of a new, rapid HCV test that can be used with venous blood, finger stick blood, serum, plasma, or oral fluid and compared it to FDA-approved laboratory methods. STUDYDESIGN:
HCV positive subjects as well as subjects at low risk for HCV were tested with the rapid test using all 5 specimen types and results compared to FDA-approved laboratory methods. In addition, performance was assessed in commercially available seroconversion panels.RESULTS:
Sensitivity and specificity of the rapid test was equivalent to laboratory EIA and performance was comparable across all 5 specimen types.CONCLUSIONS:
The OraQuick HCV Rapid Antibody Test appears suitable as an aid in the diagnosis of HCV infection.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Juego de Reactivos para Diagnóstico
/
Técnicas para Inmunoenzimas
/
Hepatitis C
/
Sistemas de Atención de Punto
Tipo de estudio:
Diagnostic_studies
Límite:
Humans
Idioma:
En
Año:
2010
Tipo del documento:
Article